drugset / Trial / NCT02532036

MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection

NCT02532036

RandomizedParallel-groupQuadruple-blindOther

Summary

TB040 is a clinical trial to investigate and compare the effects of a candidate Tuberculosis (TB) vaccine, MVA85A, administered by the aerosol inhaled route and the intramuscular route in healthy adult volunteers who are latently infected with Mycobacterium tuberculosis.

Timeline

Start
2015-09
Primary completion
2018-10-04
Completion
2018-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MVA85A Vaccine 1e+07 unknown Inhaled
Subject MVA85A Vaccine 5e+07 unknown Inhaled

Indications